Since starting Comend we’ve had the privilege to join several accelerators, each bringing new lessons, experiences, and insights. PharmStars is special in the way that it was the first that had significant thesis overlap with Comend, and also in the way that the program is structured. Over the course of 10 weeks we got a 101 on the business and industry of big pharma, and had the chance to pitch and meet with delegates from several of the largest pharma companies.
We’re incredibly grateful for Naomi and Meredith’s diligent and extensive administration of the cohort, educational lectures, and connections with industry professionals. We couldn’t have made it to the showcase event without the support of our advisors Jill and Christi, both of whom worked tirelessly with us to iterate on our value proposition, pitch, and deck.
Among the companies we’d like to thank for their time are:
- Astrazeneca (Alexion and Evinova)
- Chiesi
- Takeda
- Sanofi
- Novo Nordisk
- Genmab
We’re excited to be entering a new relationship with PharmStars, with them becoming not only mentors, but also investors. To anyone wondering if they should join a future cohort; we highly recommend it!
We wish the best of luck to our cohort-mates.
